Search for: "Maker v. Maker" Results 261 - 280 of 7,149
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2023, 2:45 am by Frank Cranmer
The ET had reached an impermissible or inadequately explained conclusion in attributing the views of Mr Conlan (who had chaired the disciplinary panel of three governors) to all other decision-makers. [read post]
19 Jun 2023, 6:26 am
This issue was recently addressed by the Divisional Court in the administrative context in Grogan v Ontario College of Teachers, 2023 ONSC 2980.[1] Deliberative secrecy protects against the disclosure of how and why decision-makers reached their decision. [read post]
14 Jun 2023, 3:29 am by David Pocklington
The proposal will result in the provision of about 571 new burial spaces; 202 in Section V and 369 in Section 5 [8] [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
8 Jun 2023, 11:48 am by Mark Walsh
Anyone who paid attention to the lively argument in that case in March will recall that Kagan was quite skeptical of the claims, as well as the humor, alleged by the maker of parody dog toys. [read post]
8 Jun 2023, 8:25 am by Florian Mueller
Here's the new complaint against Volvo, which interestingly was filed on the same day (yesterday) on which IV gave a formal patent-specific infringement notice to the Swedish car maker: Intellectual Ventures I LLC and Intellectual Ventures II LLC v. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Among the two most significant was a 2016 complaint by Pfizer alleging that claimed that Johnson & Johnson—the maker of Remicade, a best-selling medication for autoimmune disease—threatened not to pay rebates to PBMs unless they excluded from their formulary Pfizer’s biosimilar imitator to Remicade: Inflectra. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Among the two most significant was a 2016 complaint by Pfizer alleging that claimed that Johnson & Johnson—the maker of Remicade, a best-selling medication for autoimmune disease—threatened not to pay rebates to PBMs unless they excluded from their form [read post]
7 Jun 2023, 5:16 pm by Karen Gullo
Arteaga asked for detailed information of the search process, with an expert testifying the necessity of that material, but the trial court denied those requests.Police should not be allowed to use “black box” technology developed by private software makers in criminal cases without scrutiny. [read post]
7 Jun 2023, 8:30 am by Guest Author
”[6]   Despite the importance of assessing all important impacts, decision makers often focus on one impact or target or “silo,” and neglect the broader array.[7]  Assessing all important impacts is a crucial and classic calling, but a cognitive challenge. [read post]